WHO grants EUL to CanSinoBIO’s Covid-19 vaccine
The decision is based on the totality of scientific data, including findings from a Phase III trial of Convidecia.
coronavirus
PostEra and NIH partner for AI-powered antiviral development
ASAP consortium will leverage the end-to-end AI-first approach of PostEra to expedite the drug discovery process.
Ascentage’s drug shows potential to treat Covid-19 in preclinical study
Olverembatinib showed increased Omicron-NTD-mediated cytokine release suppression compared with ponatinib and baricitinib.
FDA grants EUA for Pfizer-BioNTech’s Covid-19 booster in children
The expanded EUA for use of booster dose in children is based on the findings from a Phase II/III clinical…
FDA declines to grant EUA for antidepressant to treat Covid-19
The data was inadequate to conclude that the drug was effective in preventing disease progression, FDA noted.
EC to terminate Covid-19 vaccine deal with Valneva
The EC can terminate the agreement if the vaccine does not obtain marketing authorisation from EMA by the end of…
Pfizer and BioNTech amend Covid-19 vaccine supply deal with EC
The vaccine doses planned to be supplied between June and August will now be delivered from September to Q4 of…
Sound Pharmaceuticals receives NIH grant for Covid-19 therapy development
The grant will support two trials of ebselen in 120 adult subjects with moderate or severe Covid-19.